The Initial QuantiFERON-Lyme Prototype is Unsuitable for European Patients.

Baarsma, M E; van de Schoor, F R; Van den Wijngaard, C C; Joosten, L A B; Kullberg, Bart Jan; Hovius, Joppe W

Baarsma, M E; van de Schoor, F R; Van den Wijngaard, C C; Joosten, L A B; Kullberg, Bart Jan; Hovius, Joppe W.

Afiliação

Baarsma ME; Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam Institute for Infection and Immunology, Amsterdam, The Netherlands.
van de Schoor FR; Radboudumc, Department of Internal Medicine, Radboud Center for Infectious Diseases (RCI) and Radboud Institute of Health Sciences (RIHS), Nijmegen, The Netherlands.
Van den Wijngaard CC; National Institute for Public Health and the Environment (RIVM), Center of Infectious Disease Control, Bilthoven, The Netherlands.
Joosten LAB; Radboudumc, Department of Internal Medicine, Radboud Center for Infectious Diseases (RCI) and Radboud Institute of Health Sciences (RIHS), Nijmegen, The Netherlands.
Kullberg BJ; Radboudumc, Department of Internal Medicine, Radboud Center for Infectious Diseases (RCI) and Radboud Institute of Health Sciences (RIHS), Nijmegen, The Netherlands.
Hovius JW; Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam Institute for Infection and Immunology, Amsterdam, The Netherlands.

Clin Infect Dis ; 73(6): 1125-1126, 2021 09 15.

Article em En | MEDLINE | ID: mdl-33744944

Assuntos

Testes de Liberação de Interferon-gama; Doença de Lyme; Anticorpos Antibacterianos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Lyme / Testes de Liberação de Interferon-gama Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google